Table 3.
Factors associated with 45-day mortality in MERS patients
| Factor | P | HR | 95% CI for HR | P | aHR | 95% CI for aHR | ||
|---|---|---|---|---|---|---|---|---|
| Gender | ||||||||
| Male | 1.0 | 1.0 | ||||||
| Female | 0.081 | 0.8 | 0.617 | 1.029 | 0.858 | 1.0 | 0.787 | 1.334 |
| Age | ||||||||
| <30 years | 1.0 | 1.0 | ||||||
| 30–59 years | 0.009* | 2.3 | 1.233 | 4.249 | 0.328 | 1.4 | 0.730 | 2.571 |
| 60–65 years | 0.001* | 3.9 | 1.988 | 7.500 | 0.171 | 1.6 | 0.813 | 3.204 |
| >65 years | 0.001* | 6.1 | 3.292 | 11.261 | 0.013* | 2.3 | 1.187 | 4.280 |
| Region | ||||||||
| Republic of Korea or other countries | 1.0 | 1.0 | ||||||
| Middle East | 0.018* | 3.3 | 1.233 | 9.014 | 0.017* | 4.1 | 1.288 | 13.076 |
| Saudi Arabia | 0.001* | 5.3 | 2.349 | 11.835 | 0.002* | 5.0 | 1.856 | 13.581 |
| Healthcare worker | ||||||||
| Yes | 1.0 | 1.0 | ||||||
| No | 0.001* | 11.1 | 4.580 | 26.833 | 0.001* | 5.2 | 2.056 | 13.025 |
| Comorbidity | ||||||||
| No | 1.0 | 1.0 | ||||||
| Yes | 0.001* | 5.5 | 3.624 | 8.352 | 0.001* | 2.7 | 1.710 | 4.273 |
| Symptomatic | ||||||||
| No | 1.0 | 1.0 | ||||||
| Yes | 0.001* | 7.1 | 2.935 | 17.175 | 0.011* | 3.2 | 1.306 | 7.730 |
| Source of infection | ||||||||
| Household | 1.0 | 1.0 | ||||||
| Camels | 0.001* | 4.2 | 2.093 | 8.355 | 0.010* | 2.5 | 1.254 | 5.091 |
| Healthcare-associated MERS | 0.001* | 3.6 | 1.823 | 7.061 | 0.001* | 3.6 | 1.790 | 7.078 |
| Unknown | 0.001* | 4.6 | 2.316 | 9.085 | 0.002* | 3.0 | 1.502 | 5.943 |
*Significant at α = 0.05; HR, unadjusted hazard ratios; aHR, adjusted hazard ratios.